CARDIAC GLYCOSIDES

Name of Drug Classification Mechanism of Indication Contraindicatio Adverse Nursing

Action n Reactions Responsibilities
Generic Name: General -exerts -manifest and - hyperkalemia Cardiovascular Before
-Lanoxicaps Classification hemodynamic, chronic cardiac - renal artery : - Consider the
electrophysiolog insufficiency stenosis, Arrhythmia, 10 rights of drug
-Lanoxin
ic, and conduction
-arrhythmia pregnancy administration
neurohormonal disturbances,
effects on the absoluta - pregnancy - Consider the
Functional bigeminy,
cardiovascular -paroxysmal ( category D) principles in
trigeminy, PR
Trade Name: Classification: system. It supraventricular - renal administering
prolongation,
- Digoxin Antidysrhythmic reversibly tachycardia impairment sinus medications
s inhibits the Na- - hyponatremia bradycardia - Assess for
K ATPase - hypovolemia contraindication
enzyme, leading GI: s to this drug to
Patient’s Dose: to various Nausea,
beneficial prevent potential
vomiting,
effects. adverse effects
diarrhea, lower
stomach pain - Monitor apical
Maximum Dose: -stimulates the Patient’s pulse for 1 full
varies parasympathetic Indication: min before
Nervous
nervous system administering
system:
via the vagus Central nervous - Before
Minimum Dose: nerve leading to system (CNS) administering
sinoatrial (SA)
varies disturbances, initial loading
and dizziness,
atrioventricular dose, determine
drowsiness,
(AV) node whether patient
headache
effects, has taken any
decreasing the digoxin in the
Skin:
heart rate. Skin rashes of preceding 2–3
urticarial or wk.
scarlatiniform
character
During
Metabolic: - Educate patient
Anorexia or loss on importance of
of appetite
healthy lifestyle
choices which
Ocular:
Blurred vision include regular
or visual exercise, weight
disturbances loss, smoking
cessation, and
Other: lowsodium diet
Central nervous - Administer
system (CNS)
drug on empty
disturbances,
dizziness, stomach one
drowsiness, hour before or
headache two hours after
meal to ensure
Side Effects optimum drug
-Nausea absorption.
-vomiting -Assess pulse
-headache rhythm to detect
-loss of appetite arrhythmias
-diarrhea which are early
signs of drug
toxicity.
- Monitor for
presence of
manifestations
that signal
decreased in
fluid volume
(e.g. diarrhea,
vomiting,
dehydration).
- Educate patient
and family
members about
drug’s effect to
the
Body

After
- Monitor patient
response to
therapy through
blood
pressure
monitoring.
- Monitor intake
and output ratios
and daily
weights. Assess
for peripheral
edema, and
auscultate lungs
for
rales/crackles
throughout
therapy.
Weigh the
patient daily to
monitor for fluid
retention and
HF. Assess
dependent areas
for presence of
edema and note
its degree of
pitting to assess
severity of fluid
retention.
- Evaluate
patient
understanding
on drug therapy.
- Monitor patient
compliance to
drug therapy